Cargando…

Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?

BACKGROUND: An increased risk of cardiovascular (CV) complications has been described in patients with rheumatoid arthritis (RA). It is the result of the combined effect of classic CV risk factors and others that are specific to the disease. METHODS: We assessed data from 448 early arthritis (EA) pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Ortiz, Ana M., Ortiz, Ana M., Pérez, Silvia, Toledano, Esther, Abásolo, Lydia, González-Gay, Miguel A., Castañeda, Santos, González-Álvaro, Isidoro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488761/ https://www.ncbi.nlm.nih.gov/pubmed/32917272 http://dx.doi.org/10.1186/s13075-020-02307-8

Ejemplares similares

Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis
por: González-Álvaro, Isidoro, et al.
Publicado: (2016)

Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients
por: Regueiro, Cristina, et al.
Publicado: (2018)

Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach
por: Lezcano-Valverde, José M., et al.
Publicado: (2017)

Relationship between low-density lipoprotein cholesterol and severe acute pancreatitis (“the lipid paradox”)
por: Hong, Wandong, et al.
Publicado: (2018)

A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
por: Ibañez, Monica, et al.
Publicado: (2010)

Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2020)

Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
por: Pradhan, Akshyaya, et al.
Publicado: (2023)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020)

Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
por: Cannet, Claire, et al.
Publicado: (2020)

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
por: Hirano, Tsutomu, et al.
Publicado: (2022)

Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020)

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Association Between Sebum, Total Cholesterol, and Low-Density Lipoprotein (LDL) Cholesterol Levels With Post-acne Keloids
por: Kurniawati, Yuli, et al.
Publicado: (2023)

LDL retention time in plasma can be -based on causation- estimated by the lipid composition of LDL and other lipoproteins
por: Jansen, Martin, et al.
Publicado: (2022)

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
por: Schwartz, Gregory G., et al.
Publicado: (2021)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
por: Llorente, Irene, et al.
Publicado: (2017)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics
por: Regueiro, Cristina, et al.
Publicado: (2019)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements
por: Yeang, Calvin, et al.
Publicado: (2021)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

Paradoxical Elevation of High Density Lipoprotein Cholesterol in Association with Lacunar-Type Cerebral Infarction
por: Meng, Gui-Lin, et al.
Publicado: (2015)

Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease
por: Leon, Leticia, et al.
Publicado: (2023)

Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience)
por: Kolovou, Genovefa, et al.
Publicado: (2012)

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
por: Regueiro, Cristina, et al.
Publicado: (2021)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

Propofol’s paradox, explained
por: Sedwick, Caitlin
Publicado: (2018)

Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol
por: Larsson, Anders, et al.
Publicado: (2018)

Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?
por: Baruch, Lawrence, et al.
Publicado: (2013)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Influence of menopause on high density lipoprotein-cholesterol and lipids.
por: Kim, C. J., et al.
Publicado: (2000)

A Novel Method for Estimating Low-Density Lipoprotein (LDL) Levels: Total Cholesterol and Non-High-Density Lipoprotein (HDL) Can Be Used to Predict Abnormal LDL Level in an Apparently Healthy Population
por: Zhang, Guo-Ming, et al.
Publicado: (2018)

Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies
por: Rodriguez-Martínez, Lorena, et al.
Publicado: (2020)

Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis
por: González-Álvaro, Isidoro, et al.
Publicado: (2011)

LDL-Cholesterol Increases the Transcytosis of Molecules through Endothelial Monolayers
por: Magalhaes, Ana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7uoq0vk68vqdd3e8efm75fpi9g